Prostatic Neoplasms: all 6,484 studies
Page 7 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Selecting Hypoxic Tumours for Treatment ModificationRecruitingNCT06787053
- A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPCRecruitingNCT06785636Phase 1/2
- Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy TestingRecruitingNCT06785441
- Impact of Using the Airseal System with Ultra-low Pneumoperitoneum in Patients Undergoing Robot-assisted Radical Prostatectomy: a Prospective, Comparative, Randomized Clinical Study.RecruitingNCT06784986Phase 4
- A Reminder App to Optimize Bladder Filling in Patients with Prostate Cancer Receiving HYPO-fractionated RadiotherapyNot yet recruitingNCT06784115Not applicable
- A Study of SHR-4394 Injection in Subjects With Prostate CancerRecruitingNCT06783829Phase 1
- Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate CancerRecruitingNCT06783127
- Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted TherapyRecruitingNCT06780670Phase 2/3
- A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationRecruitingNCT06778863Phase 1
- Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0.RecruitingNCT06776172Not applicable
- CHLORDECONE EXPOSURE AND PROSTATE CANCER IN THE FRENCH REGION OF MARTINIIQUERecruitingNCT06773806
- Validation of a Machine Learning Model Based on MR for the Prediction of Prostate CancerRecruitingNCT06773598
- Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial)RecruitingNCT06772441Phase 2
- Focal Therapy in Localized Prostate Cancer: a Prospective RegistryNot yet recruitingNCT06772116
- HS-10502 Combination Treatment in Patients With Advanced Solid TumorsRecruitingNCT06769425Phase 1
- Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPCNot yet recruitingNCT06768255Phase 3
- Internet-based Support for Adjustment to Prostate CancerRecruitingNCT06766526Not applicable
- Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy IntegrationRecruitingNCT06762379
- Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility StudyRecruitingNCT06759701Early Phase 1
- Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PETRecruitingNCT06758882Phase 2
- Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and MetastasisRecruitingNCT06756334Early Phase 1
- Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory ApprovalAvailableNCT06751524
- A Study of DM002 in Patients With Advanced Solid TumorsRecruitingNCT06751329Phase 1/2
- A Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General PracticeRecruitingNCT06748456Not applicable
- Study of HRS-2189 Combined HRS-5041 in Prostate CancerNot yet recruitingNCT06738745Phase 2
- Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate CancerRecruitingNCT06738303Phase 2
- The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate CancerRecruitingNCT06737588
- Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active SurveillanceRecruitingNCT06733350Phase 4
- The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer PatientsEnrolling by invitationNCT06723665Not applicable
- Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-TrialRecruitingNCT06720532
- Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan StudyRecruitingNCT06719206Not applicable
- Efficacy and Tolerability of Low-Dose Enzalutamide in Prostate CancerNot yet recruitingNCT06718647
- Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary CancersRecruitingNCT06717711Phase 3
- The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic ProfilingRecruitingNCT06717295
- The PROSECCA Study, Answering New Questions in Prostate CancerRecruitingNCT06714630
- APACA-Apheresis/acoustophoresis and Molecular Characterization of Prostate CancerRecruitingNCT06709326Not applicable
- Prognostic Study of Via Dynamic Change of dT-DNA in Drainage Fluid After Radical ProstatectomyNot yet recruitingNCT06707974
- Prognostic Study of Via Dynamic Change of PCA3 mRNA in Drainage Fluid After Radical ProstatectomyNot yet recruitingNCT06707961
- 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate CancerRecruitingNCT06706921Phase 4
- Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)RecruitingNCT06705803
- Novel ACK1 Inhibitor (R)-9b in Patients With Prostate CancerRecruitingNCT06705686Phase 1
- Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.RecruitingNCT06700057
- A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate CancerRecruitingNCT06696326Not applicable
- Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)RecruitingNCT06691776Not applicable
- Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease PatientsRecruitingNCT06690970
- A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and PrednisoneRecruitingNCT06689163Phase 1/2
- Implementation of Precision Medicine in High-risk Prostate CancerRecruitingNCT06687421
- The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in OncologyRecruitingNCT06685562
- Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate CancerRecruitingNCT06684652Not applicable
- Ivonescimab in the Treatment of Multiple Advanced TumorsRecruitingNCT06683846Phase 2
- Study on Human Bioequivalence of Triprerelin Acetate for InjectionRecruitingNCT06683066Phase 1
- Clinical Utility of ClarityDX ProstateEnrolling by invitationNCT06678828Not applicable
- Adaptive Versus Non-adaptive Radiotherapy and 2 Bladder Filling Instructions for Patients With Intermediate or High Risk Localized Prostate Cancer (ARP)RecruitingNCT06678126Phase 2
- Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative BiopsyRecruitingNCT06677775
- Using FAPI PET/MRI to Evaluate Prostate CancerRecruitingNCT06675357Phase 2
- Addressing Health Literacy With a Tailored Survivorship Care PlanRecruitingNCT06674863Not applicable
- Brodalumab in the Treatment of Immune-Related Adverse EventsRecruitingNCT06673329Phase 1
- NEWPROMRI-PATHWAY - A New Prostate Magnetic Resonance Imaging (MRI) PathwayRecruitingNCT06672926
- Oncological Prognosis of Prostate Lesions by Chemical Exchange Saturation Transfer Magnetic Resonance Imaging (CEST-MRI)Not yet recruitingNCT06669273Not applicable
- Study of SYN818 for the Treatment of Advanced or Metastatic Solid TumorsRecruitingNCT06666270Phase 1
- Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety MarginsRecruitingNCT06665932Not applicable
- RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment FailureRecruitingNCT06663007Phase 1/2
- Artificial Intelligence Models for Precision Prediction and Treatment of Prostate CancerNot yet recruitingNCT06662708Not applicable
- Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.Not yet recruitingNCT06660862Phase 4
- Prostate Tissue BioBankRecruitingNCT06659614
- Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate CancerRecruitingNCT06657131
- Combination of TURP and Standard Systemic Therapy for MPCaRecruitingNCT06655259Phase 2
- Reminder App to Optimize Bladder Filling During Radiotherapy for Prostate CancerNot yet recruitingNCT06653751Not applicable
- PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate CancerRecruitingNCT06652607
- Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer SurvivorsRecruitingNCT06651359Not applicable
- REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac TrialRecruitingNCT06650579Phase 3
- Chronic Radiation Induced Bowel Toxicity StudyRecruitingNCT06640959
- Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 FractionsRecruitingNCT06638541Not applicable
- Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative CoagulopathyNot yet recruitingNCT06637943
- Prospective Evaluation of Proclarix® Test to Improve Risk Stratification in Men Scheduled for MpMRI and Prostate Biopsy in Cantonal Hospital AarauRecruitingNCT06637267
- High Resolution Diffusion Weighted Imaging in ProstateRecruitingNCT06636747
- FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate CancerRecruitingNCT06636682Phase 2
- The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).RecruitingNCT06636526
- The Diagnostic Value of FAPI PET/CT in Staging of Newly Diagnosed Prostate CancerNot yet recruitingNCT06634173Not applicable
- Targeted Treatment for Metastatic Prostate Cancer, The PREDICT TrialRecruitingNCT06632977Phase 2
- Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate CancerRecruitingNCT06631521Phase 1
- Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer CareRecruitingNCT06630962Not applicable
- Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)RecruitingNCT06626386
- Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of RelapseRecruitingNCT06625970Phase 3
- Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate CancerRecruitingNCT06625034Phase 3
- Partial Prostatectomy for Prostate CancerRecruitingNCT06624813Not applicable
- PET Scan Study to Detect Prostate Cancer in Patients with Early PSA RecurrenceRecruitingNCT06617481Phase 2
- Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate CancerRecruitingNCT06616597Phase 2
- Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate CancerRecruitingNCT06616155Phase 1/2
- Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer PatientsRecruitingNCT06615752Phase 1/2
- A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR PathwayNot yet recruitingNCT06614751Phase 1
- Evaluation of Neoadjuvant Xaluritamig in Localized Prostate CancerRecruitingNCT06613100Phase 1
- 68Ga-AAZTA-NI-093 PET/CT: First-in-human StudyRecruitingNCT06612580Early Phase 1
- Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate CancerRecruitingNCT06612047
- Prostate Cancer Care Disparity Analysis Project (ProGAP)RecruitingNCT06612034
- Castrate Resistant Prostate Cancer Enhertu TherapyRecruitingNCT06610825Phase 2
- A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate CancerRecruitingNCT06609005Phase 1/2
- Prognostic Study of Prostate Cancer Via Dynamic Change of PSA in Peritoneal Drainage Fluid After Radical ProstatectomyNot yet recruitingNCT06608225
- PRostate Cancer Enhanced Diagnosis by Calibration TechnologyRecruitingNCT06607783
- Plasma Exosome RNA to Diagnose Prostate CancerEnrolling by invitationNCT06604130Not applicable